Dentium CO., LTD (KRX:145720)
49,750
-150 (-0.30%)
At close: Feb 11, 2026
Dentium CO., LTD Market Cap
Dentium CO., LTD has a market cap or net worth of 429.04 billion as of February 11, 2026. Its market cap has decreased by -24.51% in one year.
Market Cap
429.04B
Enterprise Value
615.22B
Revenue
356.03B
Ranking
n/a
PE Ratio
10.19
Stock Price
49,750.00
Market Cap Chart
Since March 15, 2017, Dentium CO., LTD's market cap has increased from 295.94B to 429.04B, an increase of 44.97%. That is a compound annual growth rate of 4.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 430.33B | 8.01% |
| Dec 30, 2025 | 398.42B | -25.72% |
| Dec 30, 2024 | 536.41B | -52.52% |
| Dec 28, 2023 | 1.13T | 31.00% |
| Dec 29, 2022 | 862.39B | 43.27% |
| Dec 30, 2021 | 601.95B | 69.83% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Mar 15, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 79.16T |
| Celltrion | 50.32T |
| ALTEOGEN | 20.64T |
| Sam Chun Dang Pharm. | 12.56T |
| EuBiologics | 499.84B |
| BINEX | 479.31B |
| InBody Co.,Ltd | 431.00B |
| T&L Co., Ltd. | 427.01B |